Physician profile
Amna Imran
NPI 1790281103
$3,983.74
in general payments reported to CMS, 2019-2025
35 companies · $1,243 in 2025
The $1,243 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2021: $102 · 2022: $71.60 · 2023: $215 · 2024: $2,213 · 2025: $1,243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,672.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,671.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $597.08 | 2024-2025 | Briviact, Nayzilam, Fintepla |
| Abbvie INC. | $489.18 | 2021-2025 | |
| Jazz Pharmaceuticals INC. | $363.51 | 2023-2025 | Xywav |
| Pfizer INC. | $313.31 | 2024-2025 | |
| Eisai INC. | $199.85 | 2024-2025 | |
| Sk Life Science, INC. | $177.90 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $164.20 | 2024-2025 | |
| Abbott Laboratories | $138.21 | 2019 | |
| Tanabe Pharma America, INC. | $118.22 | 2023-2025 | Radicava |
| Lilly USA, LLC | $117.49 | 2022-2025 | Kisunla, Amyvid, Emgality |
| Neurocrine Biosciences, INC. | $106.14 | 2024-2025 | Ingrezza |
| Catalyst Pharmaceuticals, INC. | $99.10 | 2024 | |
| Acadia Pharmaceuticals INC | $95.96 | 2024-2025 | Nuplazid, Daybue |
| Sumitomo Pharma America, INC. | $95.69 | 2023-2024 | Aptiom |
| Lundbeck LLC | $92.35 | 2024-2025 | Vyepti |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $74.16 | 2024-2025 | Crexont, Brekiya, Rytary |
| Azurity Pharmaceuticals, INC. | $70.73 | 2024 | Horizant |
| E.R. Squibb & Sons, L.L.C. | $70.65 | 2024 | Zeposia |
| Argenx US, INC. | $65.36 | 2025 | Vyvgart Hytrulo, Vyvgart |
| Janssen Biotech, INC. | $60.66 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $53.68 | 2023-2024 | Hyqvia |
| Boston Scientific Corporation | $50.69 | 2024-2025 | Wavewriter Alpha Prime 16 |
| Averitas Pharma INC. | $46.92 | 2025 | Qutenza |
| Cala Health, INC. | $40.08 | 2025 | Cala Kiq |
| Avadel Cns Pharmaceuticals, LLC | $36.81 | 2024 | Lumryz |
| Kyowa Kirin, INC. | $35.19 | 2022-2024 | Nourianz |
| Avanir Pharmaceuticals, INC. | $32.85 | 2022 | |
| Amgen INC. | $29.63 | 2024 | Uplizna |
| Acorda Therapeutics, INC | $25.14 | 2024 | Inbrija |
| Harmony Biosciences LLC | $25.02 | 2024 | |
| Impel Pharmaceuticals LLC | $24.92 | 2025 | Trudhesa |
| Teva Pharmaceuticals USA, INC. | $23.54 | 2025 | Austedo Xr |
| Biogen, INC. | $18.72 | 2024 | Spinraza |
| Astrazeneca Pharmaceuticals LP | $17.17 | 2024 | Wainua |
| Aucta Pharmaceuticals, INC. | $13.63 | 2025 | Motpoly Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amna Imran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.